Related Experiment Video
Updated: Jul 25, 2026
07:46
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
In vitro evaluation of faropenem activity against anaerobic bacteria
J Behra-Miellet1, L Dubreuil, A Bryskier
1Faculté de Pharmacie, 3, rue du Professeur Laguesse, BP 83, 59006 Lille cedex, France.
Journal of Chemotherapy (Florence, Italy)
|April 15, 2005
Summary
Faropenem shows strong in vitro activity against anaerobic bacteria, comparable to meropenem and imipenem. This new oral antibiotic is a promising option for empirical treatment of anaerobic infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Anaerobic bacterial infections pose a significant clinical challenge.
- Limited data exists on the efficacy of newer antibiotics, such as faropenem, against anaerobic pathogens.
- Broad-spectrum oral antibiotics are needed for empirical treatment of these infections.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of faropenem against a large collection of anaerobic bacteria.
- To compare faropenem's efficacy with established antimicrobial agents.
- To assess the potential of faropenem as an empirical treatment for anaerobic infections.
Main Methods:
- Agar dilution method following NCCLS standards.
- Testing of 462 anaerobic bacterial strains.
- Comparison with 9 positive antimicrobial controls including metronidazole, imipenem, and meropenem.
Main Results:
- Faropenem exhibited high in vitro activity against both Gram-negative and Gram-positive anaerobes.
- Minimal Inhibitory Concentrations (MIC50/90) for faropenem were 0.12/1 mg/L (Gram-negative) and 0.25/1 mg/L (Gram-positive).
- Resistance to faropenem was observed in only 1.1% of tested strains (Bacteroides fragilis group), comparing favorably to other drugs.
Conclusions:
- Faropenem demonstrates potent antimicrobial activity against anaerobic bacteria.
- Its efficacy is comparable to carbapenems like imipenem and meropenem.
- Faropenem is a viable candidate for empirical therapy in anaerobic bacterial infections.
